BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Deloitte
Healthtrust
Farmers Insurance
AstraZeneca
Fish and Richardson
Mallinckrodt
Medtronic
Teva

Generated: January 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022460

« Back to Dashboard

NDA 022460 describes JALYN, which is a drug marketed by Glaxosmithkline and is included in one NDA. It is available from three suppliers. Additional details are available on the JALYN profile page.

The generic ingredient in JALYN is dutasteride; tamsulosin hydrochloride. There are seventeen drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the dutasteride; tamsulosin hydrochloride profile page.
Summary for 022460
Tradename:JALYN
Applicant:Glaxosmithkline
Ingredient:dutasteride; tamsulosin hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 022460
Suppliers and Packaging for NDA: 022460
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460 NDA GlaxoSmithKline LLC 0173-0809 0173-0809-59 90 CAPSULE in 1 BOTTLE (0173-0809-59)
JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460 NDA GlaxoSmithKline LLC 0173-0809 0173-0809-13 30 CAPSULE in 1 BOTTLE (0173-0809-13)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength0.5MG;0.4MG
Approval Date:Jun 14, 2010TE:ABRLD:Yes

Expired US Patents for NDA 022460

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Subscribe ➤ Subscribe
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Subscribe ➤ Subscribe
Glaxosmithkline JALYN dutasteride; tamsulosin hydrochloride CAPSULE;ORAL 022460-001 Jun 14, 2010 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Federal Trade Commission
Baxter
Harvard Business School
Deloitte
Fuji
Cantor Fitzgerald
Covington
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot